title: Anti-Inflammatory mechanisms of enteric Heligmosomoides polygyrus infection against trinitrobenzene sulfonic acid-induced colitis in a murine model.
abstract: Recent studies showed that enteric helminth infection improved symptoms in patients with inflammatory bowel disease as well as in experimental models of colitis. The aim of this study was to determine the mechanism of the protective effect of helminth infection on colitis-induced changes in immune and epithelial cell function. BALB/c mice received an oral infection of Heligmosomoides polygyrus third-stage larvae, were given intrarectal saline or trinitrobenzene sulfonic acid (TNBS) on day 10 postinfection, and were studied 4 days later. Separate groups of mice received intrarectal saline or TNBS on day 10 and were studied on day 14. Muscle-free colonic mucosae were mounted in Ussing chambers to measure mucosal permeability and secretion. Expression of cytokines was assessed by quantitative real-time PCR, and mast cells were visualized by immunohistochemistry. TNBS-induced colitis induced mucosal damage, upregulated Th1 cytokines, and depressed secretory responses. Heligmosomoides polygyrus elevated Th2 cytokine expression, increased mast cell infiltration and mucosal resistance, and also reduced some secretory responses. Prior H. polygyrus infection prevented TNBS-induced upregulation of Th1 cytokines and normalized secretory responses to specific agonists. TNBS-induced colitis did not alter H. polygyrus-induced mast cell infiltration or upregulation of Th2 cytokine expression. The results indicate that the protective mechanism of enteric nematode infection against TNBS-induced colitis involves prevention of Th1 cytokine expression and improved colonic function by a mechanism that may involve mast cell-mediated protection of neural control of secretory function. Similar response patterns could account for the clinical improvement seen in inflammatory bowel disease with helminthic therapy.
authors.affiliation: Department of Pediatrics, Walter Reed Army Medical Center, Washington, DC 20307, USA.
authors.forename: Thomas L
authors.initials: TL
authors.lastname: Sutton
authors.forename: Aiping
authors.initials: A
authors.lastname: Zhao
authors.forename: Kathleen B
authors.initials: KB
authors.lastname: Madden
authors.forename: Justin E
authors.initials: JE
authors.lastname: Elfrey
authors.forename: Blaine A
authors.initials: BA
authors.lastname: Tuft
authors.forename: Carolyn A
authors.initials: CA
authors.lastname: Sullivan
authors.forename: Joseph F
authors.initials: JF
authors.lastname: Urban
authors.forename: Terez
authors.initials: T
authors.lastname: Shea-Donohue
mesh_terms: D000818:Animals; D003092:Colitis / Q000139:chemically induced / Q000276:immunology*; D003106:Colon / Q000737:chemistry / Q000473:pathology; D016207:Cytokines / Q000096:biosynthesis; D005122:Exudates and Transudates; D005260:Female; D007249:Inflammation / Q000473:pathology*; D007413:Intestinal Mucosa / Q000737:chemistry / Q000473:pathology; D008407:Mast Cells / Q000276:immunology; D051379:Mice; D008807:Mice, Inbred BALB C; D009351:Nematospiroides dubius / Q000502:physiology*; D014302:Trinitrobenzenesulfonic Acid
chemical_list: D016207:Cytokines; D014302:Trinitrobenzenesulfonic Acid